RHUMBLINE ADVISERS - G1 THERAPEUTICS INC ownership

G1 THERAPEUTICS INC's ticker is GTHX and the CUSIP is 3621LQ109. A total of 120 filers reported holding G1 THERAPEUTICS INC in Q3 2020. The put-call ratio across all filers is 58.13 and the average weighting 0.1%.

Quarter-by-quarter ownership
RHUMBLINE ADVISERS ownership history of G1 THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$1,392
-42.2%
9670.0%0.00%
Q2 2023$2,407
-99.3%
967
-97.9%
0.00%
Q1 2022$358,000
-25.6%
47,109
-0.0%
0.00%
-100.0%
Q4 2021$481,000
-23.9%
47,125
+0.1%
0.00%0.0%
Q3 2021$632,000
-37.4%
47,060
+2.3%
0.00%0.0%
Q2 2021$1,009,000
-15.2%
45,982
-7.1%
0.00%
-50.0%
Q1 2021$1,190,000
+22.9%
49,478
-8.1%
0.00%
+100.0%
Q4 2020$968,000
+74.1%
53,835
+11.9%
0.00%0.0%
Q3 2020$556,000
-58.1%
48,117
-12.1%
0.00%
-50.0%
Q2 2020$1,328,000
+152.5%
54,759
+14.8%
0.00%
+100.0%
Q1 2020$526,000
-56.3%
47,716
+4.8%
0.00%
-50.0%
Q4 2019$1,203,000
+15.2%
45,524
-0.7%
0.00%0.0%
Q3 2019$1,044,000
-22.7%
45,839
+4.0%
0.00%
-33.3%
Q2 2019$1,351,000
+172.9%
44,056
+47.8%
0.00%
+200.0%
Q1 2019$495,000
-8.5%
29,815
+5.6%
0.00%0.0%
Q4 2018$541,000
-44.0%
28,246
+52.9%
0.00%
-50.0%
Q3 2018$966,000
+13.9%
18,474
-5.3%
0.00%0.0%
Q2 2018$848,000
+94.9%
19,502
+66.3%
0.00%
+100.0%
Q1 2018$435,00011,7300.00%
Other shareholders
G1 THERAPEUTICS INC shareholders Q3 2020
NameSharesValueWeighting ↓
Cormorant Asset Management, LP 994,287$19,041,0001.55%
HHLR ADVISORS, LTD. 949,431$18,182,0000.75%
BB BIOTECH AG 671,925$12,867,0000.41%
Rhenman & Partners Asset Management AB 172,820$3,310,0000.38%
Birchview Capital, LP 15,000$287,0000.27%
Rock Springs Capital Management LP 100,000$1,915,0000.09%
SECOR Capital Advisors, LP 32,591$624,0000.08%
MARSHALL WACE, LLP 386,510$7,402,0000.08%
SIGNATUREFD, LLC 37,942$727,0000.07%
A.R.T. Advisors, LLC 38,125$730,0000.05%
View complete list of G1 THERAPEUTICS INC shareholders